Elion Therapeutics

Transforming the treatment of invasive fungal infections.

New York, United States · $81.0M raised

Headquarters
New York
Business Model
B2B
Total Funding
$81.0M
Last Round
$81.0M Series BJun 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Elion Therapeutics is a biotechnology company focused on transforming the treatment of invasive fungal infections. The company's seasoned leadership team represents more than 200 years of collective expertise in antifungal drug development, spanning large pharma, academia, and clinical medicine. Elion is built on the belief that mechanistic insights enable the targeted optimization of natural products, allowing the company to develop novel antifungal agents that address critical unmet needs in both efficacy and safety. The company's pipeline targets life-threatening invasive fungal infections, for which current treatment options are limited by toxicity, drug resistance, and narrow-spectrum coverage. Elion closed an $81 million Series B financing round in June 2024 and has continued advancing its antifungal pipeline.

Summary

Elion Therapeutics is a Biotech company based in New York, United States. It has raised $81.0M in total across 1 round, most recently a $81.0M Series B round in Jun 2024. Investors include Deerfield Management, AMR Action Fund and Illinois Ventures.

Funding History

Series BSeries BJun 2024
$81.0M

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Elion Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/elion-therapeutics"><img src="https://indexed.vc/api/badge/company/elion-therapeutics" alt="Elion Therapeutics on Indexed.vc" width="260" height="76" /></a>